Search

everythinglearnresearchcommunity

for

Search:↓

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

COVID-19 vaccination may cause kidney inflammation, treatable with steroids and Cellcept.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

Immuno-cosmeceuticals from chicken egg yolk can effectively repair and improve damaged hair.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

Pertussis toxin may contribute to hair loss in alopecia areata.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Autoimmune skin diseases result from genetic and environmental factors disrupting immune checkpoints.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Leflunomide and anthralin may effectively treat severe alopecia areata.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Human skin models are essential for studying skin's sensory, immune, and nervous system interactions.